Showing results (261-270 of 1,918) with videos related to
Sort By:
Pageof 192
Current Drug Metabolism|June 13, 2009
Transport of nucleoside analogs across the plasma membrane: a clue to understanding drug-induced cytotoxicityI Huber-Ruano, M Pastor-AngladaCurrent Drug Metabolism|June 13, 2009
Bioavailability of flavonoids: a review of their membrane transport and the function of bilitranslocase in animal and plant organismsSabina Passamonti, Michela Terdoslavich, Raffaella Franca, et al.Current Drug Metabolism|June 13, 2009
Drug-drug interactions of triazole antifungal agents in multimorbid patients and implications for patient careYasmine Nivoix, Geneviève Ubeaud-Sequier, Pauline Engel, et al.Current Drug Metabolism|June 13, 2009
Drug metabolizing enzymes and transporters mRNA in peripheral blood mononuclear cells of healthy subjects: biological variations and importance of pre-analytical stepsGérard Siest, Elise Jeannesson, Jean-Brice Marteau, et al.Current Drug Metabolism|June 13, 2009
Towards a quantitative framework for the prediction of DDIs arising from cytochrome P450 inductionL M Almond, J Yang, M Jamei, et al.Current Drug Metabolism|August 26, 2009
Insights into the structure, function, and regulation of human cytochrome P450 1A2Shu-Feng Zhou, Eli Chan, Zhi-Wei Zhou, et al.Current Drug Metabolism|August 26, 2009
The heme oxygenase/biliverdin reductase pathway in drug research and developmentC Mancuso, E BaroneCurrent Drug Metabolism|August 26, 2009
Role of phase II drug metabolizing enzymes in cancer chemopreventionSnehasis Jana, Sandhya MandlekarCurrent Drug Metabolism|October 6, 2009
Influence of genetic polymorphisms on the pharmacokinetics and pharmaco-dynamics of sulfonylurea drugsHongmei Xu, Michael Murray, Andrew John McLachlanCurrent Drug Metabolism|April 22, 2010
HMGB1-directed drug discovery targeting cutaneous inflammatory dysregulationSarah D Lamore, Christopher M Cabello, Georg T WondrakPageof 192